Page last updated: 2024-10-23

berberine and Carcinoma, Pancreatic Ductal

berberine has been researched along with Carcinoma, Pancreatic Ductal in 2 studies

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
" Here, we show that treatment of pancreatic ductal adenocarcinoma (PDAC) cells (PANC-1, MiaPaCa-2) with the isoquinoline alkaloid berberine (0."3.80Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells. ( Eibl, G; Ming, M; Rozengurt, E; Sinnett-Smith, J; Soares, HP; Wang, J; Young, SH, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
McCubrey, JA1
Abrams, SL1
Steelman, LS1
Cocco, L1
Ratti, S1
Martelli, AM1
Lombardi, P1
Gizak, A1
Duda, P1
Ming, M1
Sinnett-Smith, J1
Wang, J1
Soares, HP1
Young, SH1
Eibl, G1
Rozengurt, E1

Other Studies

2 other studies available for berberine and Carcinoma, Pancreatic Ductal

ArticleYear
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
    Biomolecules, 2022, 02-08, Volume: 12, Issue:2

    Topics: Berberine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Pancreatic Ne

2022
Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Acetyl-CoA Carboxylase; Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Berberine; Carcinoma

2014